Article Information
History
- August 12, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Javier Rodríguez-Carrio1,2,#,
- Mercedes Alperi-López2,3,
- Patricia López1,2,
- Ángel I. Pérez-Álvarez4,
- George A. Robinson5,
- Sara Alonso-Castro2,3,
- Núria Amigó6,7,8,
- Fabiola Atzeni9 and
- Ana Suárez1,3
- 1Area of Immunology, Department of Functional Biology, Faculty of Medicine, University of Oviedo, Oviedo, Spain
- 2Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain
- 3Department of Rheumatology, Hospital Universitario Central de Asturias, Oviedo, Spain
- 4Department of Neurology, Hospital Universitario Central de Asturias, Oviedo, Spain
- 5Centre for Adolescent Rheumatology versus Arthritis, Department of Medicine, University College London, London, United Kingdom
- 6Biosfer Teslab, SL, Reus, Spain
- 7Department of Basic Medical Sciences, Pere Virgili Health Research Institute (IISPV), Universitat Rovira i Virgili (URV), 43007 Reus, Spain
- 8Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBER-DEM), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain
- 9Rheumatology Unit, Department of Experimental and Internal Medicine, University of Messina, Messina, Italy
- ↵#Corresponding author:
Javier Rodríguez-Carrio, MSc, PhD, Area of Immunology, Department of Functional Biology, Faculty of Medicine, University of Oviedo, Campus El Cristo, C/ Julián Clavería s/n, L-19, 33006 – Oviedo, Spain, E-mail: rodriguezcjavier{at}uniovi.es, Phone number: +34 98510 2789
Posted August 12, 2022.
Humoral responses against HDL particles are linked to lipoprotein traits, atherosclerosis occurrence, inflammation and pathogenic pathways during the earliest stages of arthritis
